IT1402549B1 - Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnostici - Google Patents
Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnosticiInfo
- Publication number
- IT1402549B1 IT1402549B1 ITMI2010A002037A ITMI20102037A IT1402549B1 IT 1402549 B1 IT1402549 B1 IT 1402549B1 IT MI2010A002037 A ITMI2010A002037 A IT MI2010A002037A IT MI20102037 A ITMI20102037 A IT MI20102037A IT 1402549 B1 IT1402549 B1 IT 1402549B1
- Authority
- IT
- Italy
- Prior art keywords
- gpr17
- modulate
- therapeutic
- compositions
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A002037A IT1402549B1 (it) | 2010-11-03 | 2010-11-03 | Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnostici |
| EP11797264.6A EP2635275B1 (en) | 2010-11-03 | 2011-11-02 | Gpr17-modulating compounds, diagnostic and therapeutic uses thereof |
| PCT/IB2011/054865 WO2012059869A1 (en) | 2010-11-03 | 2011-11-02 | Gpr17-modulating compounds, diagnostic and therapeutic uses thereof |
| ES11797264.6T ES2512447T3 (es) | 2010-11-03 | 2011-11-02 | Compuestos que modulan el Gpr17, diagnóstico y uso terapéutico de estos |
| US13/883,097 US20140148472A1 (en) | 2010-11-03 | 2011-11-02 | Gpr17-modulating compounds, diagnostic and therapeutic uses thereof |
| US14/556,007 US20150094348A1 (en) | 2010-11-03 | 2014-11-28 | Gpr17-modulating compounds, diagnostic and therapeutic uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A002037A IT1402549B1 (it) | 2010-11-03 | 2010-11-03 | Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnostici |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20102037A1 ITMI20102037A1 (it) | 2012-05-04 |
| IT1402549B1 true IT1402549B1 (it) | 2013-09-13 |
Family
ID=43742657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI2010A002037A IT1402549B1 (it) | 2010-11-03 | 2010-11-03 | Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnostici |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140148472A1 (it) |
| EP (1) | EP2635275B1 (it) |
| ES (1) | ES2512447T3 (it) |
| IT (1) | IT1402549B1 (it) |
| WO (1) | WO2012059869A1 (it) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103505731A (zh) * | 2012-06-15 | 2014-01-15 | 中国药科大学 | 1型半胱氨酰白三烯受体拮抗剂在制备用于治疗阿尔茨海默病的药物中的用途 |
| TW202016088A (zh) * | 2018-06-19 | 2020-05-01 | 德商Ｕｃｂ製藥有限公司 | 吡啶基及吡基-（氮）吲哚磺醯胺 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20042007A1 (it) * | 2004-10-21 | 2005-01-21 | Consiglio Nazionale Ricerche | "modulatori del ricettore gpr17 e loro impieghi terapeutici" |
-
2010
- 2010-11-03 IT ITMI2010A002037A patent/IT1402549B1/it active
-
2011
- 2011-11-02 EP EP11797264.6A patent/EP2635275B1/en not_active Not-in-force
- 2011-11-02 US US13/883,097 patent/US20140148472A1/en not_active Abandoned
- 2011-11-02 WO PCT/IB2011/054865 patent/WO2012059869A1/en active Application Filing
- 2011-11-02 ES ES11797264.6T patent/ES2512447T3/es active Active
-
2014
- 2014-11-28 US US14/556,007 patent/US20150094348A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20102037A1 (it) | 2012-05-04 |
| WO2012059869A1 (en) | 2012-05-10 |
| EP2635275B1 (en) | 2014-08-06 |
| US20150094348A1 (en) | 2015-04-02 |
| ES2512447T3 (es) | 2014-10-24 |
| US20140148472A1 (en) | 2014-05-29 |
| EP2635275A1 (en) | 2013-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| BR112013002845A2 (pt) | combinação de susbtâncias ativas | |
| DK3257890T3 (da) | Tværbindelig sammensætning | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| BR112012031667A2 (pt) | composição | |
| DK2580243T3 (da) | Antibodies against human cd38 | |
| BR112012033478A2 (pt) | dispositivo médico | |
| SMT201600261B (it) | Composti oligopeptidici e loro usi | |
| DK2525798T3 (da) | Anæstetisk formulering | |
| BR112012032683A2 (pt) | composição | |
| DK2648516T3 (da) | Substituerede pyridinon-pyridinylforbindelser | |
| EE201300005A (et) | Ravimkoostis | |
| IT1402326B1 (it) | Dispositivo endoscopico | |
| DK2547349T3 (da) | Kræftterapi med en parvovirus kombineret med en HDAC-hæmmer | |
| BR112012032980A2 (pt) | composição | |
| CU23987B1 (es) | Equipo médico | |
| DE112011103919A5 (de) | Endoskop | |
| DK2450737T3 (da) | Hurtigakse-kollimatorenhed | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| FR2957252B1 (fr) | Composition cosmetique | |
| DK2642980T3 (da) | Pædiatrisk formulering | |
| BR112012029461A2 (pt) | composição farmacêutica contendo solifenacina | |
| BR112013014291A2 (pt) | formulação lipossômica de calcetrapib | |
| FR2961401B1 (fr) | Composition anti-inflammatoire | |
| IT1402549B1 (it) | Composti e composizioni che modulano gpr17 e loro usi terapeutici e diagnostici |